ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $674,208 | +18.0% | 7,200 | +12.5% | 0.04% | +18.9% |
| Q2 2023 | $571,200 | -33.4% | 6,400 | -20.0% | 0.04% | -27.5% |
| Q1 2023 | $857,760 | -3.8% | 8,000 | +9.6% | 0.05% | +10.9% |
| Q4 2022 | $891,549 | +72.8% | 7,300 | +46.0% | 0.05% | +142.1% |
| Q3 2022 | $516,000 | +11.0% | 5,000 | -0.0% | 0.02% | +46.2% |
| Q2 2022 | $465,000 | +72.2% | 5,001 | +117.4% | 0.01% | +62.5% |
| Q1 2022 | $270,000 | -59.9% | 2,300 | -54.0% | 0.01% | -52.9% |
| Q4 2021 | $673,000 | +111.0% | 5,000 | +149.5% | 0.02% | +112.5% |
| Q3 2021 | $319,000 | +21.3% | 2,004 | +0.2% | 0.01% | 0.0% |
| Q2 2021 | $263,000 | -48.9% | 2,000 | -40.1% | 0.01% | -68.0% |
| Q3 2020 | $515,000 | – | 3,340 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |